# Developmental Funds

> **NIH NIH P30** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2021 · $581,092

## Abstract

DEVELOPMENTAL FUNDS: SUMMARY
The Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC) utilizes the Cancer
Center Support Grant (CCSG) developmental funds to fuel its strategic plans for advancement of junior
investigators, team science, translational and clinical research, and support of strategic faculty recruitments.
During the current project period a total of $633,635 of CCSG developmental funds were distributed for pilot
research funding in support of nine projects. Including the CCSG funds, HCC invested a total of $2.7 million in
pilot research funds awarded between 2013-2018, which can be directly linked to the successful award of $26
million in extramural, multi-year grant funding. This is a nearly 10-fold yield from the investment of CCSG
dollars. In addition, CCSG developmental funds supported the recruitment of three new faculty recruits
supporting the expansion of scientific expertise in the Cancer Biology (CB), Developmental Cancer
Therapeutics (DCT), and Cancer Immunology (CI) Programs. J. Alan Diehl, PhD and Professor of Biochemistry
& Molecular Biology holds the SmartState Endowed Professor of Lipidomics and Pathobiology Chair. Diehl
was recruited to MUSC in 2014 from the University of Pennsylvania to serve as the Associate Director of Basic
Science. His research is currently funded by an NCI R01 and three NCI P01s. Anand Mehta, PhD and
Professor of Cell & Molecular Pharmacology and SmartState Endowed Chair of Proteomic Biomarkers was
recruited to MUSC in 2016 from Drexel University. Mehta’s research is currently funded by an NCI U01 and
R01. Carsten Krieg, PhD is Assistant Professor of Microbiology & Immunology and recruited to MUSC in 2017
from the University of Zurich. His expertise in single cell cytometry by time of flight (CyTOF) was identified as a
priority focal area for Cancer Immunology Program. Krieg is now building a technology platform within the
HCC’s Flow Cytometry & Cell Sorting (FCCS) Shared Resource for high dimensional analysis using mass
cytometry or conventional flow cytometers and high dimensional sorting for HCC investigators. In the next
project period, the HCC requests $602,250 per year in developmental funds, 27% of the overall direct Cancer
Center Support Grant request. These funds will be utilized in meeting the following specific aims: 1) Award pilot
research funding to HCC investigators to promote team science, high risk/high reward ideas, and pre-clinical
and clinical concepts; 2) Invest in new faculty start-up packages in support of the HCC six-year strategic plan;
and 3) Support up to 20% effort for two early-stage clinical investigators annually who will be charged with
developing innovative investigator-initiated trials.

## Key facts

- **NIH application ID:** 10134282
- **Project number:** 5P30CA138313-13
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** GUSTAVO Walter LEONE
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $581,092
- **Award type:** 5
- **Project period:** 2009-04-01 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10134282

## Citation

> US National Institutes of Health, RePORTER application 10134282, Developmental Funds (5P30CA138313-13). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10134282. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*